SPPG issued correspondence on Tuesday 20th June inviting community pharmacy representatives to participate in a collaborative workshop focusing on reducing the prescribing of high dose opioids in the management of chronic non-cancer pain.
Summary
In 2020, the Minister for Health launched the Transforming Medication Safety in Northern Ireland (TMSNI) strategy in response to the World Health Organisation’s (WHO) Third Global Patient Safety Challenge ‘Medication without Harm’.
One of the key areas of work within the TMSNI strategy is to undertake a targeted improvement programme with the aim of reducing preventable harm associated with a number of high-risk medicines, including opioid analgesics.
This improvement programme will focus on opioid prescribing in chronic non-cancer pain.
In order to define this area of focus further, an initial Medication Safety Opioid Collaborative workshop will be held on Friday 4th August 2023,9.30am-3pm at Riddel Hall (CR1 & CR2), 185 Stranmillis Road, Belfast, BT9 5EE.
The workshop will provide an opportunity for key stakeholders from both primary and secondary care to discuss opioid prescribing, share some examples of best practice and consider next steps for the QI programme.
Those who wish to attend the workshop can register via this link by 5pm on Monday 17th July 2023.
CPNI have provided feedback to TMSNI that community pharmacy representatives will find it challenging to attend an in-person workshop during pharmacy opening hours. An online / evening event is being considered and CPNI will update the network if further dates or times are added.
Action
Contractors should:
Read the correspondence and share with relevant members of the pharmacy team.
Register by 5pm on Monday 17th July for those who wish to attend workshop.
In the event that it is not possible to attend, contact CPNI to raise any specific points or suggestions on this topic which you would like to have raised on your behalf.
The PGD was updated to allow some primary vaccinations to take place after 30 June 2023 as per DHNI letter. This change is detailed in the PGD change history on page 3.
ACTION
Contractors providing the CPVS are asked to:
Review CPVS Update 10, and the previous updates (1-9 linked above) if not already reviewed.
Ensure that you are working to the most up to date version of the PGD and that it has been internally authorised.
Should you have further queries please contact CPNI offices or a member of the SPPG vaccination team.
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
The police cybercrime unit has advised CPNI of a phishing campaign detected in Northern Ireland recently.
Details
The police indicate that the phishing emails contain similar links structured as:
google.co.uk/amp/s/[sendercompany name]notion.site/[sender company name – alphanumeric string]
Clicking the link then redirects the user to a spoofed Microsoft ‘Sign In’ page looking to capture and compromise credentials.
Similar to previous campaigns, attackers exploit the compromised account by sending phishing emails to contacts within the victims email account.
Action
Contractors are advised to:
(a) Inform staff of these reported incidents; (b) Note the advice and guidance given on the CPNI website cyber security page (here) in respect of steps you can take to protect your data and businesses; and (c) Report any incidents of email compromise to www.actionfraud.police.uk.
Contractors and their IT support will have their own internal procedures to follow when a system is compromised, and the police would encourage users to report any such incident, secure the account and notify any interested parties to help minimise the risk of further compromises.
Contractors are also reminded that the storage and back up of patient sensitive data and any amendments to your systems should only be carried out in line with advice from your IT or email supplier, PMR system provider and in line with Data Protection legislation.
CPNI colleagues will continue to keep you updated on these matters.
Kind regards
Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY Head of Regulatory Affairs
Dear Contractor
DHSC and MHRA have updated the list of medicines which, because they are needed for UK patients, cannot be exported from the UK or hoarded.
The following have been added to the list of medicines:
16 June 2023
Semaglutide, all strengths, tablets; Dulaglutide, all strengths, solution for injection; Exenatide, all strengths, solution for injection; Liraglutide, 6mg/ml, solution for injection; Insulin degludec + Liraglutide, 100units/ml + 3.6mg/ml, solution for injection.
Cyclizine 50mg/1ml solution for injection ampoules
5
£9.74
Doxycycline 100mg capsules
8
£0.95
Flucloxacillin 125mg/5ml oral solution
100
£2.70
Flucloxacillin 250mg/5ml oral solution
100
£3.91
Flucloxacillin 250mg/5ml oral solution sugar free
100
£3.60
Fluoxetine 20mg/5ml oral solution
70
£10.49
Frovatriptan 2.5mg tablets
6
£12.93
Hydroxocobalamin 1mg/1ml solution for injection ampoules
5
£11.35
Hydroxychloroquine 200mg tablets
60
£5.09
Ivabradine 2.5mg tablets
56
£47.16
Lansoprazole 15mg orodispersible tablets
28
£3.06
Leflunomide 20mg tablets
30
£3.43
Levetiracetam 100mg/ml oral solution sugar free
300
£10.45
Lofepramine 70mg tablets
56
£13.23
Mebeverine 135mg tablets
100
£6.46
Mometasone 0.1% ointment
30
£4.36
Mometasone 50micrograms/dose nasal spray
140
£2.88
Naftidrofuryl 100mg capsules
84
£10.79
Nebivolol 2.5mg tablets
28
£13.03
Nitrofurantoin 100mg tablets
28
£12.24
Nitrofurantoin 50mg tablets
28
£12.25
Omeprazole 10mg gastro-resistant capsules
28
£1.78
Omeprazole 20mg gastro-resistant capsules
28
£2.04
Perindopril erbumine 2mg tablets
30
£1.27
Perindopril erbumine 4mg tablets
30
£1.75
Perindopril erbumine 8mg tablets
30
£2.40
Phenoxymethylpenicillin 125mg/5ml oral solution
100
£9.30
Phenoxymethylpenicillin 250mg/5ml oral solution
100
£10.20
Pramipexole 180microgram tablets
30
£8.22
Pregabalin 150mg capsules
56
£2.68
Pregabalin 75mg capsules
56
£2.17
Prochlorperazine 3mg buccal tablets
50
£8.43
Prochlorperazine 5mg tablets
28
£2.01
Quetiapine 300mg tablets
60
£4.08
Sodium cromoglicate 2% eye drops
13.5
£2.59
Spironolactone 100mg tablets
28
£5.10
Spironolactone 25mg tablets
28
£1.97
Tamsulosin 400microgram modified-release capsules
30
£1.75
Telmisartan 80mg tablets
28
£2.86
Terbinafine 1% cream
30
£3.78
Terbinafine 1% cream
15
£3.27
Tolterodine 1mg tablets
56
£2.73
Topiramate 25mg tablets
60
£8.99
Topiramate 50mg tablets
60
£17.79
Valsartan 40mg capsules
28
£6.75
Valsartan 80mg capsules
28
£7.94
Zopiclone 3.75mg tablets
28
£1.95
Zopiclone 7.5mg tablets
28
£1.75
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
